| 1 |
35205815 | Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth. | 2022 Feb 20 |
1 |
| 2 |
33392641 | Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer. | 2021 Mar |
1 |
| 3 |
33663586 | Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma. | 2021 Mar 4 |
1 |
| 4 |
32780889 | The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia. | 2020 Dec |
2 |
| 5 |
30353642 | CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL. | 2019 Jan |
1 |
| 6 |
31545402 | CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2. | 2019 Nov |
3 |
| 7 |
28139498 | Enhanced efficacy of 5-fluorouracil in combination with a dual histone deacetylase and phosphatidylinositide 3-kinase inhibitor (CUDC-907) in colorectal cancer cells. | 2017 Jan-Feb |
1 |
| 8 |
28147336 | Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma. | 2017 Feb 21 |
1 |